Patents by Inventor Jeffrey Michael MARRA

Jeffrey Michael MARRA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OXIME-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AS ORL-1 MODULATORS
    Publication number: 20150238485
    Abstract: The present disclosure relates to Oxime-Substituted Quinoxaline-Type Piperidine Compounds, such as those of Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R20, R21, Q, Y1, Z, A, B, and a are as defined herein; compositions comprising an effective amount of an Oxime-Substituted Quinoxaline-Type Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of an Oxime-Substituted Quinoxaline-Type Piperidine Compound.
    Type: Application
    Filed: May 7, 2015
    Publication date: August 27, 2015
    Inventors: Jeffrey Michael MARRA, Naoki TSUNO, Tatsuhiko UENO, Xiaoming ZHOU
  • Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators
    Patent number: 9040533
    Abstract: The present disclosure relates to Oxime-Substituted Quinoxaline-Type Piperidine Compounds, such as those of Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R20, R21, Q, Y1, Z, A, B, and a are as defined herein; compositions comprising an effective amount of an Oxime-Substituted Quinoxaline-Type Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of an Oxime-Substituted Quinoxaline-Type Piperidine Compound.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: May 26, 2015
    Assignees: Purdue Pharma L.P., Shionogi & Co., Ltd.
    Inventors: Jeffrey Michael Marra, Naoki Tsuno, Tatsuhiko Ueno, Xiaoming Zhou
  • OXIME-SUBSTITUTED-QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20140187544
    Abstract: The present disclosure relates to Oxime-Substituted Quinoxaline-Type Piperidine Compounds, such as those of Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R20, R21, Q, Y1, Z, A, B, and a are as defined herein; compositions comprising an effective amount of an Oxime-Substituted Quinoxaline-Type Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of an Oxime-Substituted Quinoxaline-Type Piperidine Compound.
    Type: Application
    Filed: December 23, 2013
    Publication date: July 3, 2014
    Applicants: Shionogi & Co., Ltd., Purdue Pharma L.P.
    Inventors: Jeffrey Michael MARRA, Naoki Tsuno, Tatsuhiko Ueno, Xiaoming Zhou